Dr. Albert Friesen

The founder, President, CEO and Chair of the Board of Medicure Inc., Dr. Friesen holds a Ph.D. in protein chemistry from the University of Manitoba.  Dr. Friesen played a key role in founding several health industry companies including the first employee and President of the Winnipeg Rh Institute for over 20 years,where he oversaw the development of WinRho (then acquired by Cangene Inc. and more recently by Emergent BioSolutions), ABI Biotechnology (now Apotex Fermentation Inc.), Viventia Biotech Inc.(Eleven BioTherapeutics), Genesys Pharma Inc., DiaMedica Inc, Miraculins Inc., Kane Biotech Inc. and KAM Scientific Inc. Dr. Friesen has experience in the establishment of pharmaceutical production facilities and has also managed and initiated the research and clinical development of several pharmaceutical candidates. Dr. Friesen is a founder of the Industrial Biotechnology Association of Canada (IBAC) and past Chairman of its board of directors and former member of the Industrial Advisory Committee to the Biotechnology Research Institute in Montreal. In addition to his role with the Company, Dr. Friesen is currently the President and Chairman of Genesys Venture Inc., a biotech incubator, based in Winnipeg. Dr. Friesen provides his services to the Companies through A.D. Friesen Enterprises Ltd., his private consulting corporation. Dr. Friesen’s date of birth is May 19, 1947. He is the recipient Distinguished Alumni Award, University of Manitoba – 2003;  Order of Manitoba– 2005; Life Science Award – Individual Contribution to the Industry – Life Science Association of Manitoba – 2007; The Industry Leadership Gold Leaf Award by BIOTECanada – 2013